PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19) Meeting Abstract
| Authors: | Aggarwal, R.; Heller, G.; Hillman, D.; Xiao, H.; Picus, J.; Wang, J.; Taplin, M. E.; Dorff, T.; Appleman, L. J.; Weckstein, D.; Patnaik, A.; Bryce, A. H.; Shevrin, D.; Mohler, J.; Anderson, D.; Rao, A.; Tagawa, S. T.; Tan, A.; Eggener, S.; Morris, M. J. |
| Abstract Title: | PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1428 |
| Language: | English |
| ACCESSION: | WOS:000866211602476 |
| DOI: | 10.1016/j.annonc.2022.08.066 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA63 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
